A 30-Year Quest For Alzheimer's Remedy Nears The Finish Line

  • TauRx will soon unveil human trial results for its drug LMTX
  • Singapore company's backers include Genting Berhad and Temasek

Claude Wischik.

Source: University of Aberdeen

After decades of researching a treatment for Alzheimer’s, Claude Wischik is set to find out whether his lonely 30-year battle can lead to one of the first real treatments for the memory-destroying brain disorder that afflicts millions worldwide.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.